BD&L Summit · Munich · November 2026

Europe's Premier
Life Sciences
Dealmaking Summit

Where the world’s leading BD&L executives and decision-makers converge to discover transformative opportunities, strategic partnerships, and high value deals.

The BioPharma Deals Conference unites global biopharma executives, investors, and dealmakers to explore licensing opportunities, strategic partnerships, co-development, M&A, and commercial collaborations. Two days of high-level networking, curated partnering meetings, and executive discussions designed to accelerate innovation and business growth in life sciences.

24th & 25th November 2026
Munich, Germany
200+ Senior BD&L Leaders
Register Now View Programme
Event at a Glance
BioPharma Deals — BD&L Summit 2026
Dates: 24th & 25th November 2026
Venue: Science Congress Center, Munich
Audience: Pharma · Biotech · Investors · Service & Solution Providers · Platforms
Focus: Licensing Deals · Alliances · M&A · Corporate Partnerships · Co-Development · Out-Sourcing · External Innovation · Investments
Format: Panel discussions · Keynotes · Company Presentations · One to One Meetings
Secure Your Seat →
scroll
BD&L Leaders
Expert Speakers
2 Intensive Days
1 European Hub
BioPharma BD&L dealmakers networking BD&L Summit keynote speaker
2026 BD&L
Summit
Europe's BD&L Epicentre

Where Pharma Biotech
Deals Get Done

The BioPharma Deals Conference is the gathering point for the Pharma Biotech dealmakers to initiate, advance, and close deals.

This is not a general pharma congress. It is an exclusive, targeted and BD&L focused summit where every session, every meeting, and every curated interaction is designed with a potential to generate real commercial outcomes, licensing agreements, co-development mandates, investment conversations, and strategic partnerships that reshape pipelines.

Licensing M&A Co-Development Partnering Capital Raising IP Strategy
Explore the Programme
Why Attend

Engineered for Serious Dealmakers

Every element of the programme is built to create deal momentum — from the opening keynote to the final networking reception.

Deal Intelligence

Unfiltered market intelligence on licensing valuations, deal structures, milestone frameworks, and royalty benchmarks across therapy areas — delivered by experts closing deals.

Curated 1-to-1 Meetings

Pre-arranged, structured partnering sessions with the exact counterparts you need to meet — no cold introductions, no wasted time. Just focused deal conversations with decision-makers.

Expert-Led BD&L Panels

Learn from BD&L decision-makers on the topics that define successful dealmaking: term sheets, due diligence, risk allocation, and post-deal governance.

Pipeline Presentations

Showcase your pipeline, platform, or investment thesis to a room of active deal-seekers. Structured formats ensure every pitch reaches the right audience and generates qualified follow-on conversations.

M&A & Licensing Masterclasses

Deep-dive training sessions on the mechanics of complex transactions — from early co-development to full asset acquisition — led by advisors with decades of life sciences transactional experience.

Senior Network Access

Gain direct access to a curated peer network of VP BD and above, licensing directors, fund managers, and corporate development leaders — relationships that generate deal flow long after the summit ends.

Why BD&L Leaders Choose This Summit

The Commercial
Conversation
Life Sciences Needs

The life sciences industry survives on partnerships. Almost every drug that reaches patients represents a chain of licensing decisions, co-development agreements, and strategic alliances made by BD&L professionals. The BioPharma Deals Conference exists to elevate that discipline — giving the industry's dealmakers the intelligence, relationships, and frameworks to transact with confidence and close with conviction.

Join the Summit
85%
Senior level and above attendees
10+
Therapy areas represented
30+
Countries represented
60%
Return attendance rate
Who Attends

A Room Full of
Decision-Makers

We apply a rigorous curation process to ensure every attendee holds genuine deal authority. No passengers — every person in the room can initiate and advance a real deal.

01
Chief BD Officers & VP Business Development

Senior BD leaders from Big Pharma, Specialty Pharma, and mid-sized biopharmaceuticals responsible for licensing and partnership strategy at portfolio level.

Licensing · Partnering
02
Biotech CEOs & Founders

Leaders of innovative biotech companies at Series B through commercial stage, actively seeking licensing partners, co-development agreements, and strategic acquirers.

Out-Licensing · Fundraising
03
Life Sciences Investors

Venture capitalists, family offices, and corporate venture arms deploying capital across early and late-stage assets, evaluating in-licensing and co-investment structures.

Venture · Corporate Venture
04
Licensing Directors & Alliance Managers

Deal execution professionals responsible for structuring, negotiating, and closing licensing agreements — from term sheet through contract and ongoing alliance management.

Execution · Alliance Mgmt
05
M&A & Corporate Development Leaders

Corporate development directors and M&A advisors running buy-side and sell-side mandates across pharma, biotech, medtech, and diagnostics — from bolt-on to transformational deals.

M&A · Corporate Dev
06
Legal, IP & Financial Advisors

Specialist advisors — transactional lawyers, IP counsel, investment bankers, and financial due diligence experts — who bring deals to fruition and protect value through execution.

Legal · IP · Finance
Summit Experience

Two Days That
Change Your Pipeline

Structured to maximise deal conversations. Every session, break, and reception is engineered for meaningful commercial connection.

Company Pipeline Pitch
Pipeline Pitch
Expert BD&L Panel
BD&L Panel
1-to-1 Partnering
1:1 Partnering Sessions
Networking
Deal Networking
Innovation Exhibition
Innovation Exhibition
Summit Audience
The BD&L Community
Why This Summit

The BD&L Event
Designed Around Industry Needs

Life sciences conferences are abundant, but few are truly deal-focused. A conference built exclusively for BD&L professionals — with the depth, rigour, and deal focus they require.

BD&L-Exclusive Agenda

Every session addresses a real challenge in business development and licensing — valuation, term structuring, partner identification, alliance governance. No science updates, no tangential content. Pure BD&L.

Pre-Vetted, Senior-Only Attendees

We manually review every registration. The result: a room where every conversation is worth your time and every contact has the authority and genuine intent to move a deal forward.

Commercial Outcomes, Measured

Previous attendees have reported initiating licensing term sheets, signing NDAs, and advancing investment conversations directly from meetings made at this summit. We measure our success by yours.

Munich: Europe's Life Sciences Capital

Strategically located in the heart of Europe's most dynamic life sciences cluster — with exceptional connectivity and a thriving pharma, biotech, and investor ecosystem on your doorstep.

Secure Your Place
BioPharma Deals BD&L Summit audience

"The deals that define the next decade of medicine are being initiated in rooms exactly like this — between the right people, at the right moment, with the right intelligence at hand."

BioPharma Deals Conference — BD&L Summit
Munich · 24–25 November 2026

Your Next Deal
Starts Here

Join Europe's most focused gathering of BD&L professionals. Two days. Three hundred dealmakers. One shared ambition: to close the deals that advance the science of life.

Register Now BD&L Training Course